PMID: 11933681Apr 6, 2002Paper

Advances in the management of endometrial adenocarcinoma. A review

The Journal of Reproductive Medicine
William P IrvinRoss S Berkowitz

Abstract

Endometrial adenocarcinoma is the most common and curable gynecologic neoplasm; the five-year survival for women with surgical stage I disease ranges from 83% to 93%; stage II, 73%; stage III, 52%; and stage IV, 27%. The absence of an asymptomatic latency phase amenable to detection through screening and the already excellent cure rates seen with early-stage disease have precluded the need for endometrial cancer screening programs. Adenocarcinomas constitute 97% of endometrial cancers, with endometrioid the most common histologic subtype. Two different pathways of endometrial carcinogenesis exist. One arises in a background of estrogen excess, giving rise to atypical hyperplasia as the malignant precursor of the more common endometrioid adenocarcinomas. The use of oral contraceptives has consistently been shown to decrease the risk of developing endometrial carcinoma via this pathway, with 12 months or more of continuous use decreasing the lifetime risk by 40-50%. The alternate pathway of endometrial carcinogenesis represents malignant transformation of atrophic endometrium and proceeds through endometrial intraepithelial carcinoma as the malignant precursor of the more virulent serous papillary and clear cell endometrial adeno...Continue Reading

Related Concepts

Related Feeds

Adenocarcinoma, Clear Cell

Clear Cell Adenocarcinoma is a tumor that arises in the female genital tract and is characterized by cells that appear clear under the microscope. Discover the latest research here.

Related Papers

Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology
Zorica StanojevićO Dunjic
Clinical Obstetrics and Gynecology
Marcela G Del CarmenJohn O Schorge
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
Stephanie KukuMary McCormack
The Journal of Reproductive Medicine
S Memarzadeh, J S Berek
© 2022 Meta ULC. All rights reserved